BioMed Research International / 2014 / Article / Tab 1

Research Article

Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line

Table 1

The gene list showing the fold-change in extracellular matrix related proteins in the drug-resistant sublines with respect to the parental A2780 cell line.

Gene
symbol
RefSeQ transcript
ID
Fold-change
C versus P1C versus P2C versus C1C versus C2C versus D1C versus D2C versus T1C versus T2

ITGB8NM_002214NSNSNSNSNSNS19.975.35
COL1A2NM_0000895.54NSNSNSNSNS56.5066.36
COL4A1NM_001845NS8.05NSNSNSNSNSNS
COL11A1NM_001854−29.34−149.24−106.43−56.2398−81.08NS−57.68−24.29
COL12A1NM_004370NSNS23.92NS16.35NSNSNS
COL15A1NM_001855NSNSNSNSNSNSNS10.17
COL16A1NM_0018568.85NSNSNSNSNSNSNS
COL17A1NM_00049416.79NSNSNSNSNSNSNS
COL18A1NM_0305825.90NSNSNSNSNSNSNS
COL21A1NM_03082055.13NSNSNSNSNSNSNS
LOXNM_00231735.03NSNSNSNSNSNSNS
SPARCNM_003118NSNSNSNSNSNSNS17.71
TGFBINM_000358NSNSNSNSNSNS27.9417.48
LAMA1NM_005559−18.76NSNSNSNSNSNSNS
LAMA2NM_000426NSNSNS−33.4055NSNSNSNS
LAMA4NM_001105206NSNSNSNSNSNS9.528.92
LAMB1NM_00229115.8993.16NSNS8.65NSNSNS
LAMB3NM_0002288.24NSNSNSNSNSNSNS
FN1NM_002026−5.27−5.049NSNSNSNSNSNS
FLRT2NM_013231NSNS6.37NSNSNSNSNS
FBN1NM_000138NSNS−9.21−13.3875NSNSNSNS
EFEMP1NM_001039348NSNSNSNS35.33NSNSNS
GPC3NM_004484NSNSNSNSNSNSNS23.71
GPC4NM_001448NSNSNSNSNSNSNS19.80
GPC6NM_005708−33.30NSNSNSNSNS−16.01NS
DCNNM_001920Ns−10.52NSNSNSNSNSNS
EPYCNM_004950NSNSNSNS8.5213.7955NSNS
KERANM_007035−10.79−7.94−9.65−6.08735NSNSNSNS
LUMNM_002345NS−48.58NSNSNSNSNSNS
HAPLN1NM_001884−8.73NS10.65NSNS9.290745.219.46
SDC2NM_002998NS22.5413.29NS19.13NSNSNS
KRT8NM_002273NSNSNSNSNSNSNS8.12
MGPNM_00090062.13NSNS6.213469.13NS82.90241.13

NS: up- or downregulation between 5 and −5, indicative of changes in expressions that are not statistically significant.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.